Skip to main content

Table 3 Associations of log-transformed Adipokines with systolic blood pressure and pulse wave velocity

From: Association of adipokines with blood pressure, arterial elasticity and cardiac markers in dialysis patients: cross-sectional analysis of baseline data from a cohort study

 

Model-1

Model-2

Model-3

ß

p

ß

p

ß

p

Systolic Blood Pressure

 Adiponectin

7.80

0.001

6.02

0.01

4.17

0.11

 Resistin

-10.16

0.04

-5.07

0.25

-4.25

0.34

 PAI-1

-21.71

<0.001

-12.69

0.001

-10.83

0.008

 Leptin

-8.89

<0.001

-6.89

<0.001

-6.14

0.005

 MCP-1

-5.89

0.30

-2.91

0.57

-1.38

0.79

 Adipsin

-18.20

0.009

-5.16

0.44

-3.62

0.59

Pulse Wave Velocity

 Adiponectin

-0.34

0.30

-0.80

0.02

-1.05

0.003

 Resistin

-0.84

0.23

-0.23

0.70

-0.22

0.72

 PAI-1

-0.62

0.28

0.72

0.18

0.90

0.11

 Leptin

-0.58

0.02

-0.39

0.12

-0.34

0.27

 MCP-1

-0.78

0.33

-0.26

0.71

-0.18

0.80

 Adipsin

-1.37

0.17

0.56

0.53

0.64

0.48

  1. For associations between adipokines and systolic blood pressure: Model-1: adjusted for age and sex; Model-2: adjusted for covariates in Model-1 + dialysis vintage, current smoker, interdialytic weight gain, diabetes mellitus, history of cardiovascular disease, use of antihypertensives, log – weekly EPO dose, total and HDL cholesterol; Model-3: adjusted for covariates in Model-2 + BMI and log-CRP
  2. For associations between adipokines and pulse wave velocity: Model-1: adjusted for age and sex; Model-2: adjusted for covariates in Model-1 + dialysis vintage, current smoker, interdialytic weight gain, diabetes mellitus, history of cardiovascular disease, use of antihypertensives, use of statins, total and HDL cholesterol, systolic blood pressure and log-CRP; Model-3: adjusted for covariates in Model-2 + BMI
  3. Boldface entries are significant (p<0.05)